Name: C26-Ceramide
Price: Inquiry

- Overview
  - Marker for Farber disease diagnosis
    
    Please contact us at for specific academic pricing.
- Properties
  - Categories
    
    Fine Chemicals
    
    Alternative Name
    
    N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]hexacosanamide;[R-[R*,S*-(E)]]-N-[2-Hydroxy-1-(hydroxymethyl)-3-heptadeceny l]hexacosanamide
    
    CAS Number
    
    121459-09-4
    
    Molecular Formula
    
    C44H87NO3
    
    Molecular Weight
    
    678.17 g/mol
    
    MDL Number
    
    MFCD28988613
    
    Note
    
    There is no hazardous surcharge associated with this product.
    There is no special packaging charge associated with this product.
    
    * For research use only. Not for human or veterinary use
- Reference
  - Tayama et al (1993). Effect of saposins on acid sphingomyelinase. Biochemical Journal. 290 ( Pt 2)(Pt 2):401-4.
    Holleran et al (1994). Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. Journal of Clinical Investigation. 1994 Apr;93(4):1756-64.
    Wilkening et al (1998). Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. Journal of Biological Chemistry. 273(46):30271-8.